Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/v12090987 http://scihub22266oqcxt.onion/10.3390/v12090987 32899480!7552029!32899480     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Viruses 2020 ; 12 (9): ä Nephropedia Template TP {{tp|p=32899480|t=2020. Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice |pdf=|usr=}}{{32899480}} gab.com Text Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice JO: Viruses http://www.kidney.de/pget.php?&tw=1&pmid=32899480 #FOAvip An effective vaccine is essential for controlling the spread of the SARS-CoV-2 virus. Here, we describe an influenza virus-based vaccine for SARS-CoV-2. We incorporated a membrane-anchored form of the SARS-CoV-2 spike receptor binding domain (RBD) in place of the neuraminidase (NA) coding sequence in an influenza virus also possessing a mutation that reduces the affinity of hemagglutinin for its sialic acid receptor. The resulting DeltaNA(RBD)-Flu virus can be generated by reverse genetics and grown to high titers in cell culture. A single-dose intranasal inoculation of mice with DeltaNA(RBD)-Flu elicits serum neutralizing antibody titers against SAR-CoV-2 comparable to those observed in humans following natural infection (~1:200). Furthermore, DeltaNA(RBD)-Flu itself causes no apparent disease in mice. It might be possible to produce a vaccine similar to DeltaNA(RBD)-Flu at scale by leveraging existing platforms for the production of influenza vaccines. Twit Text FOAVip Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice ????Viruses http://www.kidney.de/pget.php?&tw=1&pmid=32899480 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32899480 #FOAvip English Wikipedia <ref>{{Cite pmid|32899480}}</ref> Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice #MMPMID32899480 Loes AN; Gentles LE; Greaney AJ; Crawford KHD; Bloom JD Viruses 2020[Sep]; 12 (9): ä PMID32899480show ga An effective vaccine is essential for controlling the spread of the SARS-CoV-2 virus. Here, we describe an influenza virus-based vaccine for SARS-CoV-2. We incorporated a membrane-anchored form of the SARS-CoV-2 spike receptor binding domain (RBD) in place of the neuraminidase (NA) coding sequence in an influenza virus also possessing a mutation that reduces the affinity of hemagglutinin for its sialic acid receptor. The resulting DeltaNA(RBD)-Flu virus can be generated by reverse genetics and grown to high titers in cell culture. A single-dose intranasal inoculation of mice with DeltaNA(RBD)-Flu elicits serum neutralizing antibody titers against SAR-CoV-2 comparable to those observed in humans following natural infection (~1:200). Furthermore, DeltaNA(RBD)-Flu itself causes no apparent disease in mice. It might be possible to produce a vaccine similar to DeltaNA(RBD)-Flu at scale by leveraging existing platforms for the production of influenza vaccines. |*Coronavirus Infections[MESH] |*Influenza Vaccines[MESH] |*Influenza, Human[MESH] |*Pandemics[MESH] |*Pneumonia, Viral[MESH] |*Pregnancy Complications, Infectious[MESH] |Animals[MESH] |Antibodies, Neutralizing[MESH] |Antibodies, Viral[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Chlamydia trachomatis[MESH] |Fertility[MESH] |Humans[MESH] |Mice[MESH] |Pregnancy[MESH] |SARS-CoV-2[MESH] |Spike Glycoprotein, Coronavirus[MESH]Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Bindin(epmc).pdf DeepDyve Pubget Overpricing